Medicinální Oxid Dusný (Nitrous Oxide)

Nitrous oxide is used in clinical settings for analgesia, sedation and anesthesia across various procedures.

• Pain management: provides rapid analgesia during minor surgical or dental procedures.
• Procedural sedation: induces conscious sedation for diagnostic or therapeutic interventions.
• General anesthesia: contributes to induction and maintenance of anesthesia in combination with other agents.

• Nitrous oxide produces its clinical effects by antagonizing N‑methyl‑D‑aspartate (NMDA) receptors and modulating opioid receptors in the central nervous system. This dual action reduces excitatory neurotransmission and enhances endogenous analgesic pathways, leading to analgesia, sedation and a dissociative state. The gas also influences GABAergic activity, contributing to its anesthetic properties. The rapid onset is due to its high lipid solubility, allowing quick penetration of the brain, while elimination is primarily via exhalation, providing controllable depth of effect.

Nitrous oxide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild queasiness that may appear during or shortly after inhalation, usually self‑limiting.
• Vomiting: occasional emesis, more likely at higher concentrations or in sensitive individuals.
• Dizziness: transient light‑headedness or vertigo that resolves when the gas is discontinued.
• Headache: brief throbbing sensation that typically subsides after the procedure.
• Dry mouth: reduced salivation causing throat irritation and discomfort during use.
• Euphoria: short‑lasting feeling of well‑being that may be disorienting for some patients.

Serious or Rare Side Effects

• Hypoxia: significant drop in blood oxygen levels if nitrous oxide is not administered with sufficient supplemental oxygen.
• Respiratory depression: marked slowing of breathing, especially when combined with other central nervous system depressants.
• Loss of consciousness: unexpected deep sedation leading to unconsciousness, requiring immediate airway management.
• Vitamin B12 deficiency: prolonged or repeated exposure can inactivate cobalamin, potentially resulting in neuropathy or hematologic changes.
• Malignant hyperthermia trigger: rare but serious reaction in genetically susceptible patients, characterized by rapid rise in body temperature and muscle rigidity.

When using nitrous oxide, careful assessment and monitoring are essential to ensure patient safety.

• Patient assessment: evaluate respiratory function and contraindications before administration.
• Monitoring: continuously monitor oxygen saturation, heart rate and level of consciousness during use.
• Supplemental oxygen: always deliver nitrous oxide with an adequate flow of oxygen to prevent hypoxia.
• Contraindications: avoid in patients with severe COPD, pneumothorax, or known vitamin B12 deficiency.
• Drug interactions: be cautious when used with other sedatives, opioids or anesthetic gases.
• Store at ambient temperature: keep cylinder in a well‑ventilated, dry area, protect from heat and direct sunlight.

Nitrous oxide can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Other inhalational anesthetics: concurrent use can cause excessive sedation and respiratory depression.
• Opioids and benzodiazepines: additive CNS depressant effects increase risk of hypoventilation.
• Alcohol: combined depressant action may lead to profound sedation.

Moderate Interactions (Monitor Closely)

• Respiratory depressants (e.g., barbiturates): may require dose adjustment and close monitoring.
• Antidepressants (SSRIs, SNRIs): monitor for enhanced sedation.